跳至主要内容
临床试验/NCT05118984
NCT05118984已完成4 期

Comparison Between Azithromycin vs Placebo in Cases of Meconium Stained Amniotic Fluid During the First Stage of Labor in Multigravida Women and Their Effect on Maternal and Neonatal Outcomes, a Double-blind, Placebo-controlled Randomized Clinical Trial.

Cairo University1 个研究点 分布在 1 个国家目标入组 324 人开始时间: 2021年2月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
324
试验地点
1
主要终点
Azithromycin vs Placebo in cases of meconium stained amniotic fluid during the first stage of labor in multigravida women and their effect on occurrence of neonatal fever , pneumonia and skin infection .

研究概览

简要总结

Meconium stained amniotic fluid increases the risk of maternal complications (e.g., dystocia, operative delivery, and postpartum endometritis) and neonatal complications (e.g., sepsis, admission to the neonatal intensive care unit [NICU], and meconium aspiration syndrome). The goal of the study is to compare between Azithromycin vs Placebo in cases of meconium stained amniotic fluid during the first stage of labor in multigravida women and their effect on maternal and neonatal outcomes.

详细描述

Meconium stained amniotic fluid, a troublesome situation both for obstetrician and pediatrician, it is associated with high rates of caesarean section, perinatal morbidity and mortality. The rate of meconium-stained amniotic fluid varies from 12 to 20%.It is higher in underdeveloped countries.Our study design would be a prospective randomized trial. Consented, eligible pregnant women presenting during the first stage of labor at or more than 37 weeks of gestation with meconium stained amniotic fluid will be randomized to receive Azithromycin capsule (Zithromax, Pfizer) (250 mg / 12hrs on empty stomach for 3 days)(Group 1).Group 2 will be offered placebo capsules (manufactured in pharmacy department with the same shape, color and consistency as Azithromycin capsule for 3 days).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

盲法说明

Patients will be randomized to the 2 study groups according to a 2-block randomization list coded I or II at a 1:1 ratio. The randomization list will be prepared using a computer- generated random table by a statistician not otherwise involved in the study. The allocated groups will be masked in serially numbered sealed opaque envelopes that will be opened only after enrollment. Women who will be recruited give consent and open randomization envelopes in early labor, also the women will be recruited before revealing the allocation, the allocation will be blind to both the recruiter and the participant.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Multigravida pregnant women with meconium stained amniotic fluid encountered either by spontaneous/artificial amniotomy during the first stage of labor in the ward provided that the gestational age at delivery is 37 weeks of gestation or more.
  • Singleton living gestation
  • Cephalic presentation
  • Adequate pelvis
  • An informed written consent for the proposed study.

排除标准

  • Primigravids
  • Women with previous cesarean section
  • Multifetal gestation
  • Intrauterine fetal death
  • Malpresentations
  • Prematurity (<37 weeks )
  • Abnormally invasive placenta during the current pregnancy
  • Medical disorders with pregnancy
  • Contracted pelvis
  • Evidence of maternal infection
  • Allergy to azithromycin or other macrolides that is self-reported or documented in the medical record.

研究组 & 干预措施

Azithromycin group

Active Comparator

Azithromycin capsule (Zithromax, Pfizer) (250 mg / 12 hrs on empty stomach for 3 days).

干预措施: Azithromycin capsule (Zithromax, Pfizer) (250 mg) (Drug)

Placebo group

Placebo Comparator

placebo capsules (manufactured in pharmacy department with the same shape, color and consistency as Azithromycin capsule every 12hrs for 3 days). A single pharmacist will be responsible for manufacturing of placebo capsules and packing all medications into sterile boxes and labelling of them as 1 or 2.

干预措施: Placebo (Drug)

结局指标

主要结局

Azithromycin vs Placebo in cases of meconium stained amniotic fluid during the first stage of labor in multigravida women and their effect on occurrence of neonatal fever , pneumonia and skin infection .

时间窗: within 1 week from delivery

Neonates were followed up for incidence of neonatal pneumonia, neonatal skin infection , neonatal fever.

Azithromycin vs Placebo in cases of meconium stained amniotic fluid during the first stage of labor in multigravida women and their effect on occurrence of maternal fever, postpartum endometritis and skin (episiotomy/tear) infection.

时间窗: within 1 week from delivery

Mothers will be followed up during her stay in the postnatal ward regarding signs of infection (fever, maternal tachycardia, offensive vaginal discharge, uterine tenderness). Postpartum follow up visit 1 week after delivery will be conducted.

次要结局

  • 2- Side effects of drug (diarrhea, stomach cramps, vomiting, allergy and anaphylactic shock).(wwithin 1 week postpartum)
  • Fetal necessity for NICU admission and/or mechanical ventilation.(after delivery and within 1 week postartum)
  • Occurrence of meconium aspiration(after delivery and within 1 week postpartum)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Kamal Zaghloul

Doctor

Cairo University

研究点 (1)

Loading locations...

相似试验